<DOC>
	<DOCNO>NCT00924560</DOCNO>
	<brief_summary>This study conduct compare effect 91-day oral contraceptive ( OC ) 28-day OC regimen bone mineral density ( BMD ) adolescent female .</brief_summary>
	<brief_title>A Multicenter Study Evaluate Effects 91-day Oral Contraceptive Bone Mineral Density Adolescent Females</brief_title>
	<detailed_description>Participants randomize either 91-day OC 28-day OC . Participants seek hormonal contraception meet eligibility criterion serve control group . Duration study study participant approximately 13 month .</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy postmenarchal adolescent female 1218 year old , nonpregnant , nonlactating Regular spontaneous menstrual cycle Body mass index ( BMI ) : 18 kg/m² &lt; 30 kg/m² , weight &lt; 200 lb Others dictate Food Drug Administration ( FDA ) approve protocol Any contraindication use oral contraceptive History previous clinically significant adverse event take hormonal contraceptive Use medication could significantly interfere study assessment Others dictate FDAapproved protocol</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Adolescents</keyword>
	<keyword>Bone Mineral Density</keyword>
	<keyword>Oral Contraceptive</keyword>
</DOC>